APA

Hurvitz S., Singh R., Adams B., Taguchi J. A., Chan D., Dichmann R. A., Castrellon A., Hu E., Berkowitz J., Mani A., DiCarlo B., Callahan R., Smalberg I., Wang X., Meglar I., Martinez D., Hobbs E. & Slamon D. J. (2018). Phase Ib/II single-arm trial evaluating the combination of everolimus, lapatinib and capecitabine for the treatment of HER2-positive breast cancer with brain metastases (TRIO-US B-09). : Therapeutic advances in medical oncology.

Chicago

Hurvitz Sara, Singh Rashi, Adams Brad, Taguchi Julie A, Chan David, Dichmann Robert A, Castrellon Aurelio, Hu Eddie, Berkowitz Jonathan, Mani Aruna, DiCarlo Brian, Callahan Rena, Smalberg Ira, Wang Xiaoyan, Meglar Ivana, Martinez Diego, Hobbs Evthokia and Slamon Dennis J. 2018. Phase Ib/II single-arm trial evaluating the combination of everolimus, lapatinib and capecitabine for the treatment of HER2-positive breast cancer with brain metastases (TRIO-US B-09). : Therapeutic advances in medical oncology.

Harvard

Hurvitz S., Singh R., Adams B., Taguchi J. A., Chan D., Dichmann R. A., Castrellon A., Hu E., Berkowitz J., Mani A., DiCarlo B., Callahan R., Smalberg I., Wang X., Meglar I., Martinez D., Hobbs E. and Slamon D. J. (2018). Phase Ib/II single-arm trial evaluating the combination of everolimus, lapatinib and capecitabine for the treatment of HER2-positive breast cancer with brain metastases (TRIO-US B-09). : Therapeutic advances in medical oncology.

MLA

Hurvitz Sara, Singh Rashi, Adams Brad, Taguchi Julie A, Chan David, Dichmann Robert A, Castrellon Aurelio, Hu Eddie, Berkowitz Jonathan, Mani Aruna, DiCarlo Brian, Callahan Rena, Smalberg Ira, Wang Xiaoyan, Meglar Ivana, Martinez Diego, Hobbs Evthokia and Slamon Dennis J. Phase Ib/II single-arm trial evaluating the combination of everolimus, lapatinib and capecitabine for the treatment of HER2-positive breast cancer with brain metastases (TRIO-US B-09). : Therapeutic advances in medical oncology. 2018.